Citadel Advisors’s Vanda Pharmaceuticals VNDA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $1.32M | Buy |
|
|||||
|
2025
Q2 | $698K | Sell |
|
|||||
|
2025
Q1 | $1.14M | Sell |
|
|||||
|
2024
Q4 | $1.83M | Buy |
|
|||||
|
2024
Q3 | $668K | Sell |
|
|||||
|
2024
Q2 | $833K | Sell |
|
|||||
|
2024
Q1 | $2.98M | Buy |
|
|||||
|
2023
Q4 | $2.61M | Sell |
|
|||||
|
2023
Q3 | $2.96M | Buy |
|
|||||
|
2023
Q2 | $4.19M | Sell |
|
|||||
|
2023
Q1 | $6.91M | Buy |
|
|||||
|
2022
Q4 | $4.05M | Buy |
|
|||||
|
2022
Q3 | $867K | Buy |
|
|||||
|
2022
Q2 | $389K | Buy |
|
|||||
|
2022
Q1 | – | Hold |
|
|||||
|
2021
Q4 | – | Sell |
|
|||||
|
2021
Q3 | $672K | Sell |
|
|||||
|
2021
Q2 | $2.33M | Sell |
|
|||||
|
2021
Q1 | $2.58M | Sell |
|
|||||
|
2020
Q4 | $3.21M | Sell |
|
|||||
|
2020
Q3 | $9.12M | Buy |
|
|||||
|
2020
Q2 | $10.2M | Buy |
|
|||||
|
2020
Q1 | $3.13M | Sell |
|
|||||
|
2019
Q4 | $5.31M | Sell |
|
|||||
|
2019
Q3 | $5.49M | Buy |
|
|||||
|
2019
Q2 | $725K | Sell |
|
|||||
|
2019
Q1 | $2.31M | Sell |
|
|||||
|
2018
Q4 | $3.28M | Sell |
|
|||||
|
2018
Q3 | $9.69M | Buy |
|
|||||
|
2018
Q2 | $2.69M | Buy |
|
|||||
|
2018
Q1 | $1.3M | Sell |
|
|||||
|
2017
Q4 | $2M | Sell |
|
|||||
|
2017
Q3 | $14.1M | Buy |
|
|||||
|
2017
Q2 | $8.13M | Buy |
|
|||||
|
2017
Q1 | $6.22M | Buy |
|
|||||
|
2016
Q4 | $2.49M | Buy |
|
|||||
|
2016
Q3 | $899K | Buy |
|
|||||
|
2016
Q2 | $196K | Sell |
|
|||||
|
2016
Q1 | $508K | Sell |
|
|||||
|
2015
Q4 | $1.02M | Sell |
|
|||||
|
2015
Q3 | $1.52M | Buy |
|
|||||
|
2015
Q2 | $1.35M | Buy |
|
|||||
|
2015
Q1 | $418K | Sell |
|
|||||
|
2014
Q4 | $1.17M | Buy |
|
|||||
|
2014
Q3 | $16K | Sell |
|
|||||
|
2014
Q2 | $593K | Sell |
|
|||||
|
2014
Q1 | $1.15M | Sell |
|
|||||
|
2013
Q4 | $4.74M | Buy |
|
|||||
|
2013
Q3 | $662K | Sell |
|
|||||
|
2013
Q2 | $749K | Buy |
|